Man Group
GILD icon

Man Group’s Gilead Sciences GILD Stock Holding History

Man Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,100
Closed -$422K – 2193
2022
Q1 		$422K Buy
+7,100
New +$454K ﹤0.01% 1639

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Man Group's GILD Position: Q2 2026 in Review

Man Group increased its Gilead Sciences (GILD) stake by 82% in Q2 2026, buying an estimated $73.4M and bringing the position to 1,235,196 shares worth $156M. The position accounts for 0.25% of the portfolio, ranked #84.

Man Group first reported a position in GILD in Q1 2018 and has held it in 31 quarters since. The position peaked at $268M in Q1 2019. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Man Group held 1,235,196 shares of Gilead Sciences worth $156M as of Q2 2026.
  • Man Group bought 557,130 Gilead Sciences shares in Q2 2026, an estimated $73.4M.
  • Gilead Sciences made up 0.25% of Man Group's portfolio in Q2 2026, its #84 holding.
  • Man Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 31 quarters since.
  • Man Group's Gilead Sciences position peaked at $268M in Q1 2019.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.